Blue Trust’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
CM
Blue Trust's CHRS Position: Q3 2026 in Review
Blue Trust opened a new position in Coherus Oncology (CHRS) in Q3 2026: 2 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #2517 among its holdings.
100 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- Blue Trust held 2 shares of Coherus Oncology worth $2 as of Q3 2026.
- Coherus Oncology was a new Blue Trust position in Q3 2026.
- Coherus Oncology made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2517 holding.
- 100 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.